SPY391.86-16.46 -4.03%
DIA315.55-11.55 -3.53%
IXIC11,418.15-566.37 -4.73%

BRIEF-Global Cord Blood Corporation Announces Entry Into Cell Therapy Market By Acquiring Cellenkos And Its Products Rights

reuters.com · 04/29/2022 16:21
BRIEF-Global Cord Blood Corporation Announces Entry Into Cell Therapy Market By Acquiring Cellenkos And Its Products Rights

- Global Cord Blood Corp CO:

  • GLOBAL CORD BLOOD CORPORATION ANNOUNCES ENTRY INTO CELL THERAPY MARKET BY ACQUIRING CELLENKOS AND ITS PRODUCTS RIGHTS

  • GLOBAL CORD BLOOD - AT CLOSING, CO WILL ISSUE ABOUT 125 MILLION NEW SHARES VALUED AT US$11 PER SHARE AND PAY US$664 MILLION IN CASH AS TOTAL CONSIDERATION

Source text for Eikon: ID:nPn77NtrVa

Further company coverage: CO


((Reuters.Briefs@thomsonreuters.com;))